Nestle Skin Health SA
www.nestleskinhealth.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Nestle Skin Health SA
Nestle, Bullish On Palforzia, To Buy Remainder Of Aimmune
Bookmark
-
Analysis
Since Palforzia likely will be the only peanut allergy drug on market for some time, Nestle announces it will pay about $2.6bn to acquire the 80% of Aimmune it doesn’t own.
Cellular Biomedicine To Go Private In Consortium Buyout
Bookmark
-
News
Deal Snapshot: The China/US CAR-T firm will be bought out by its management team and institutional investors in a deal structured as a merger into a new company.
Company Information
- Industry
- Medical Devices
-
Pharmaceuticals
- OTC, Consumer
Advertisement
Advertisement